CEO SUMMARY: Department of Justice cases involving clinical labs or molecular test claims may represent about half (or about $3 billion) of the total fraudulent claims. Those claims stem from genetic testing, urine-drug and other tests, and healthcare services, the DOJ said. In addition, the DOJ reported that labs were involved in filing fraudulent claims for lab tests while working with […]
DOJ $6B Fraud Crackdown Charges 345 Defendants
Largest enforcement action in department history also ensnares molecular and drug-testing lab firms
- By Robert Michel
- > From the Volume XXVII, No. 14 - October 5, 2020 Issue
- Tags: clinical lab, clinical laboratories, Clinical Laboratory, clinical laboratory test, COVID-19 Molecular Testing, COVID-19 Rapid Testing, genetic testing, lab fraud, lab test, lab testing, laboratories, laboratory fraud, laboratory test, laboratory testing, laboratory tests, medicare fraud, medicare fraud cases, pain management, recent medicare fraud cases, substance abuse testing
